Dr. Tim Church predicted recently that GLP-1 agonists, GLP-1 /GIP agonists and similar prescription drugs will soon be as ...

GLP‑1 receptor agonists are widely recognized for aiding weight loss and controlling blood sugar, but access remains limited — especially for Medicare and Medicaid patients. That might change with a ...

The eMed Population Health digital health platform announced Tuesday that former X Chief Executive Officer Linda Yaccarino ...

Linda Yaccarino, the former CEO of the Elon Musk-owned social media platform X, has a new leadership gig in the weight loss space.

Soon after last month’s end of her turbulent two-year run as CEO of X (formerly Twitter), Linda Yaccarino has landed another ...

The telehealth company posted revenue of $544.8 million in the second quarter, marking a 73% increase year over year but missing analyst estimates for $552 million, according to Bloomberg data. Hims & ...

When it comes to weight loss, there are a number of tried and true lifestyle changes you can make to help you along the way.

After stepping down from X in July, Yaccarino is taking the CEO job at eMed Population Health, which makes a digital health platform for managing GLP-1 weight loss drugs. [Link: eMed® Population ...

New research reveals that obesity-related cancer deaths in the U.S. have surged within 20 years, with obesity linked to 13 ...